Cargando…
_version_ 1783747570141495296
author Giubilini, Alberto
Savulescu, Julian
Danchin, Margie
author_facet Giubilini, Alberto
Savulescu, Julian
Danchin, Margie
author_sort Giubilini, Alberto
collection PubMed
description
format Online
Article
Text
id pubmed-8413006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84130062021-09-03 Reply Giubilini, Alberto Savulescu, Julian Danchin, Margie J Pediatr Letter to the Editor Elsevier Inc. 2022-01 2021-08-17 /pmc/articles/PMC8413006/ /pubmed/34416261 http://dx.doi.org/10.1016/j.jpeds.2021.08.019 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Giubilini, Alberto
Savulescu, Julian
Danchin, Margie
Reply
title Reply
title_full Reply
title_fullStr Reply
title_full_unstemmed Reply
title_short Reply
title_sort reply
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413006/
https://www.ncbi.nlm.nih.gov/pubmed/34416261
http://dx.doi.org/10.1016/j.jpeds.2021.08.019
work_keys_str_mv AT giubilinialberto reply
AT savulescujulian reply
AT danchinmargie reply